ETHealthworld.com brings latest multiple sclerosis news, views and updates from all top sources for the Indian Health industry.
Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and safety in diverse patient populations. The MUSETTE trial confirmed that the ...
Millions of Australians are set to benefit from the price of medicine going down for the first time in over 20 years. From January 1, everyday Aussies will be able to access prescription medication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results